Kancera completes the third and final installment for the Fractalkine project
Kancera today announces that the third installment for the Fractalkine project and KAND567 is carried out according to the acquisition agreement. The payment that was activated in connection with the ongoing Phase Ib study takes place through a new issue of two...
Read More